Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
The coronavirus disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing major threat to global health and has posed significant challenges for the treatment of severely ill COVID-19 patients. Several studies have reported that c...
Main Authors: | Ruirong Chen, Zhien Lan, Jujian Ye, Limin Pang, Yi Liu, Wei Wu, Xiaohuan Qin, Yang Guo, Peidong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.589095/full |
Similar Items
-
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
by: Prakash Nagarkatti, et al.
Published: (2020-11-01) -
Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection
by: Mousa Ahmad Alhiyari, et al.
Published: (2021-01-01) -
Risk Factors for Reverse Transcriptase Polymerase Chain Reaction Positivity for SARS-CoV-2 among Healthcare Workers in a Group of Tertiary Care Hospitals in Mumbai: A Cross-sectional Study
by: Amit Shrenikraj Mutha, et al.
Published: (2021-04-01) -
Immunopathogenesis of severe acute respiratory syndrome coronavirus-2: evolving knowledge and its current status
by: Nitin Saksena, et al.
Published: (2021-06-01) -
Nintedanib treatment for pulmonary fibrosis after coronavirus disease 2019
by: Hiroaki Ogata, et al.
Published: (2021-05-01)